Sector: Pharmaceuticals & Biotechnology
|Small Cap
Gufic BioSciences Ltd.
₹322.90
₹315.10
₹327.75
₹268.00
₹407.85
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 231.09 | 230.42 | 226.91 | 205.02 | 207.79 |
| Operating Expense | 194.79 | 194.62 | 194.58 | 178.38 | 173.85 |
| Operating Profit | 36.31 | 35.80 | 32.34 | 26.64 | 33.94 |
| Depreciation | 7.69 | 7.77 | 7.72 | 7.84 | 4.62 |
| Interest | 8.36 | 9.58 | 9.23 | 8.40 | 4.91 |
| Tax | 5.49 | 5.59 | 4.20 | 2.81 | 6.96 |
| Net Profit | 15.56 | 14.94 | 12.07 | 7.97 | 19.32 |
₹322.90
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 72.5 | 72.5 | 72.5 | 72.5 | 72.5 | 72.5 |
| FII | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 |
| DII | 3 | 3.4 | 3.4 | 3.7 | 3.8 | 3.8 |
| Public | 24.2 | 23.8 | 23.8 | 23.5 | 23.3 | 23.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.6 L | 6.79 L | 23.63% |
| Week | 42.23 K | 1.57 L | 26.86% |
| 1 Month | 44.31 K | 98.44 K | 45.01% |
| 6 Month | 27.93 K | 53.52 K | 52.19% |
MACD Crossover Above Signal Line
Benjamin Graham Value Screen
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Overbought by Money Flow Index (MFI)
Companies with Zero Promoter Pledge
RSI indicating price strength
Stocks in uptrend most likely to cross above SMA-200 soon
MACD crossed above zero line previous end of day
MACD crossed above signal line previous end of day
Biggest Price Gainers from Open
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 22 Sep, 2025 | 0.1 | FINAL | 22 Sep, 2025 | Equity Share |
| 18 Sep, 2024 | 0.1 | FINAL | Equity Share | |
| 21 Sep, 2023 | 0.1 | FINAL | Equity Share | |
| 24 Aug, 2022 | 0.1 | FINAL | Equity Share | |
| 09 Sep, 2021 | 0.1 | FINAL | Equity Share | |
| 03 Nov, 2020 | 0.05 | FINAL | Equity Share | |
| 20 Sep, 2019 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2018 | 0.05 | FINAL | Equity Share | |
| 28 Aug, 2017 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2016 | 0.05 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹483 | ₹6.41 | ₹133.70 | ₹14.02 | ₹556.75 | ₹845.05 |
| % Change | -1.39% | -0.47% | 1.08% | 1.74% | -1.08% | -1.17% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | - | ₹502.55 | ₹1,630.02 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | - | ₹57.92 | ₹140.92 |
| PE TTM | - | -1.50 | 34.80 | - | 27.80 | 34.30 |
| 1 Year Return | 23.38 | 546 | 5.75 | 54.4 | -22.35 | -5.28 |
| ROCE | 3.56 | -5.63 | - | - | 23.87 | 15.27 |
Valiant Laboratories Ltd.
₹ 79.00
+1.41%
Sigachi Industries Ltd.
₹ 20.31
+1.45%
Windlas Biotech Ltd.
₹ 820.05
+4.43%
Vineet Laboratories Ltd.
₹ 34.50
-1.34%
Solara Active Pharma Sciences Ltd.
₹ 562.00
+1.40%
Zim Laboratories Ltd.
₹ 104.00
+4.14%
Medico Remedies Ltd.
₹ 48.39
-1.73%
Dishman Carbogen Amcis Ltd.
₹ 201.00
+0.59%
Lasa Supergenerics Ltd.
₹ 8.23
+2.11%
Advanced Enzyme Technologies Ltd.
₹ 378.00
+0.31%
Bajaj Healthcare Ltd.
₹ 306.50
+1.32%
Ortin Global Ltd.
₹ 15.90
+1.27%
Brooks Laboratories Ltd.
₹ 59.23
+5.00%
RPG Life Sciences Ltd.
₹ 2205.00
-2.16%
Bafna Pharmaceuticals Ltd.
₹ 129.50
-4.67%
Alpa Laboratories Ltd.
₹ 70.35
+3.46%
SMS Pharmaceuticals Ltd.
₹ 375.70
+1.77%
Nectar Lifesciences Ltd.
₹ 12.40
+2.06%
Mangalam Drugs and Organics Ltd.
₹ 29.00
-0.48%
Indoco Remedies Ltd.
₹ 192.00
-1.91%
Ind-Swift Laboratories Ltd.
₹ 136.20
+3.04%
Lincoln Pharmaceuticals Ltd.
₹ 755.00
+4.99%
Panacea Biotec Ltd.
₹ 424.00
+1.18%
Medicamen Biotech Ltd.
₹ 268.35
-0.85%
By signing up I certify terms, conditions & privacy policy